Sadia Rahman
Analyst
Wells Fargo
Equibles does not estimate personal net worth.
About Sadia Rahman
Sadia Rahman is recorded as Analyst at Wells Fargo. Sadia Rahman has spoken on 3 earnings calls and 5 other investor events across 7 companies, most recently for Mineralys Therapeutics, Inc. on September 9, 2026. Those appearances were for Travere Therapeutics, Inc. (TVTX), Mineralys Therapeutics, Inc. (MLYS), Maze Therapeutics, Inc. (MAZE), Vor Biopharma Inc. (VOR), Jade Biosciences, Inc. (JBIO) and 2 other companies. The companies whose calls Sadia Rahman spoke on are classified in the Healthcare sector.
Sadia Rahman on recent calls
“I'm one of the biotech analysts here at Wells, filling in for this session for Mohit. And it's my pleasure to introduce Mineralis Therapeutics. For Mineralis, we have John Congleton, CEO, Adam Levy, CFO, and Eric Warren, Chief Commercial Officer.”
“I'm one of the biotech analysts here at Wells Fargo, and it's my pleasure to introduce Maze Therapeutics for our next session. From Maze, we have Misbah Tahrir, the CFO.”
“You had a couple of announcements this morning. You also have a very important catalyst coming up in the first half of 2027, which is the Myasthenia Gravis Phase 3 readout.”
“All right, hi everyone, thanks for joining us at the Wells Fargo Healthcare Conference. My name is Sadia Rahman, one of the biotech analysts here at Wells Fargo, and it's a pleasure to introduce Jade Biosciences for our next session.”
“So maybe a big-picture question. just curious if this strong launch in FSGS has changed your confidence in your prior estimate of the size of the opportunity for Filsfari across IGAN and FSGS.”
Affiliation history
-
Wells Fargo
Analyst
Source not stated
Current